Valiant Organics Hits 52-Week Low, Underperforming Sector and Sensex
Valiant Organics, a smallcap pharmaceutical company, has hit a 52-week low on November 14, 2024. The stock has been on a downward trend for the past 5 days, with a consecutive fall of -14.1%. According to MarketsMojo, the stock has been given a 'Strong Sell' call due to its bearish trend and underperformance compared to the Sensex. Investors are advised to do their own research before investing.
Valiant Organics, a smallcap pharmaceutical company, has recently hit a 52-week low on November 14, 2024. The stock has been on a downward trend for the past 5 days, with a consecutive fall of -14.1% during this period. Today, the stock opened with a loss of -2.02% and touched an intraday low of Rs 360, underperforming the sector by -4.04%.
According to MarketsMOJO, a leading stock market analysis and recommendation platform, the stock has been given a 'Strong Sell' call. This is based on the fact that Valiant Organics is currently trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a bearish trend in the stock's performance.
In comparison to the Sensex, which has shown a positive performance of 19.81% in the past year, Valiant Organics has underperformed with a -17.05% return. This could be a cause for concern for investors.
It is important to note that this information is based on facts and data, without any mention of future potential or expert opinions. As a smallcap company in the pharmaceutical industry, Valiant Organics may face challenges in the market, which could be reflected in its stock performance. Investors are advised to do their own research and make informed decisions before investing in the stock.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
